Udit Dalwadi1, Dhiraj Mannar1, Felix Zierhut1, Calvin K Yip1. 1. Life Sciences Institute, Department of Biochemistry and Molecular Biology, The University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada.
Abstract
Conserved from yeast to humans and composed of six core subunits (Elp1-Elp6), Elongator is a multiprotein complex that catalyzes the modification of the anticodon loop of transfer RNAs (tRNAs) and in turn regulates messenger RNA decoding efficiency. Previous studies showed that yeast Elongator consists of two subassemblies (yElp1/2/3 and yElp4/5/6) and adopts an asymmetric overall architecture. Yet, much less is known about the structural properties of the orthologous human Elongator. Furthermore, the order in which the different Elongator subunits come together to form the full assembly as well as how they coordinate with one another to catalyze tRNA modification is not fully understood. Here, we purified recombinant human Elongator subunits and subassemblies and examined them by single-particle electron microscopy. We found that the human Elongator complex is assembled from two subcomplexes that share similar overall morphologies as their yeast counterparts. Complementary co-purification and pulldown assays revealed that the scaffolding subunit human ELP1 (hELP1) has stabilizing effects on the human ELP3 catalytic subunit. Furthermore, the peripheral hELP2 subunit appears to enhance the integrity and substrate-binding ability of the dimeric hELP1/2/3. Lastly, we found that hELP4/5/6 is recruited to hELP1/2/3 via hELP3. Collectively, our work generated insights into the assembly process of core human Elongator and the coordination of different subunits within this complex.
Conserved from yeast to humans and composed of six core subunits (Elp1-Elp6), Elongator is a multiprotein complex that catalyzes the modification of the anticodon loop of transfer RNAs (tRNAs) and in turn regulates messenger RNA decoding efficiency. Previous studies showed that yeast Elongator consists of two subassemblies (yElp1/2/3 and yElp4/5/6) and adopts an asymmetric overall architecture. Yet, much less is known about the structural properties of the orthologous human Elongator. Furthermore, the order in which the different Elongator subunits come together to form the full assembly as well as how they coordinate with one another to catalyze tRNA modification is not fully understood. Here, we purified recombinant human Elongator subunits and subassemblies and examined them by single-particle electron microscopy. We found that the human Elongator complex is assembled from two subcomplexes that share similar overall morphologies as their yeast counterparts. Complementary co-purification and pulldown assays revealed that the scaffolding subunit human ELP1 (hELP1) has stabilizing effects on the human ELP3 catalytic subunit. Furthermore, the peripheral hELP2 subunit appears to enhance the integrity and substrate-binding ability of the dimeric hELP1/2/3. Lastly, we found that hELP4/5/6 is recruited to hELP1/2/3 via hELP3. Collectively, our work generated insights into the assembly process of core human Elongator and the coordination of different subunits within this complex.
As a key adaptor molecule
in translation, transfer RNAs (tRNAs)
undergo a broad range of enzyme-catalyzed post-transcriptional modifications.
A hotspot of tRNA modification is position 34 or the first position
of the anticodon.[1] This tRNA nucleoside
interacts with the third position of a messenger RNA (mRNA) codon
and mediates non-Watson–Crick pairing, which allows the ribosome
to accommodate different “wobble pairs” in the decoding
process.[2] tRNA modifications at position
34 regulate wobble pairing and enhance decoding efficiency by altering
the conformation of the anticodon.[3,4] A key enzyme
in tRNA post-transcriptional modification is Elongator, which is a
multiprotein enzyme complex that specifically modifies uridine bases
at position 34 (U34).[5] In particular,
Elongator introduces a carboxymethyl group to the C5-position of this
uridine (cm5U), priming this nucleoside for subsequent
conversion to 5-carbamoylmethyl (ncm5U), 5-methoxycarbonylmethyl
(mcm5U), or 5-methoxy-carbonyl-methyl-2-thio (mcm5s2U) groups by other partner enzymes in the cascade.[6]Conserved from yeast to humans, Elongator
was originally discovered
as a component of the elongating RNA Polymerase II ternary complex.[7−11] However, further studies in fission yeast Schizosaccharomyces
pombe and budding yeast Saccharomyces
cerevisiae suggested that the most likely physiological
function of Elongator is in post-transcriptional modification of tRNA.[12−16] Subsequent tandem affinity purification analyses in yeast Saccharomyces cerevisiae revealed that Elongator
is an ∼650 kDa multiprotein complex composed of two copies
of six subunits (Elp1, Elp2, Elp3, Elp4, Elp5, and Elp6). These proteins
are arranged into two discrete subassemblies: Elp1-Elp2-Elp3 (hereafter
Elp1/2/3) and Elp4-Elp5-Elp6 (hereafter Elp4/5/6).[8,9] Often
referred to as core Elongator, Elp1/2/3 contains main catalytic subunit
Elp3 and two structural proteins Elp1 and Elp2. Elp1 and Elp2, through
their WD40 beta propeller domains, generate a scaffold that houses
Elp3 as well as mediates substrate interaction.[17] X-ray crystallographic analysis of human ELP1 (hELP1) and
yeast Elp1 (yElp1) further showed the tetratricopeptide domain at
the C-terminus of this protein mediates dimerization required for
full complex assembly.[18] The recent crystal
structure of a bacterial orthologue of Elp3 showed that this catalytic
subunit contains a catalytically inactive lysine acetyltransferase
domain, an iron–sulfur (Fe–S) cluster binding site,
and a radical S-adenosylmethionine domain that mediates the chemical
modification.[19] For Elp4/5/6, biochemical
and structural characterization of yeast Elp4/5/6 (yElp4/5/6) showed
that these proteins form a hexameric RecA ATPase-like assembly that
is capable of both hydrolyzing ATP and binding tRNA.[20,21]The overall architecture and subunit arrangement of full yeast
Elongator were recently resolved through negative stain single-particle
electron microscopy (EM) analysis of core Elongator and full Elongator
isolated from yeast S. cerevisiae.[22,23] Notably, yeast core Elongator was observed to adopt a symmetrical
bi-lobal architecture. This symmetry was broken in full Elongator
because of the yElp4/5/6 subcomplex binding to one of two lobes. More
recently, high-resolution cryo-EM analysis of yeast core Elongator
(yElp1/2/3) generated further molecular details on interaction interface
between different subunits as well as how yeast core Elongator engages
in interaction with its tRNA substrate.[24] Despite these recent advances, many fundamental questions on Elongator
remain unanswered. For example, the precise roles of the different
subunits in supporting Elongator function are not fully understood.
Furthermore, the proposed mechanism of substrate carboxymethylation
by Elongator derived from experiments using archaeal Elp3 has yet
to be validated in the context of core and full Elongator.[25]Because of its critical role in tRNA modification,
Elongator dysfunction
has been shown to affect proteome homeostasis by causing an increase
in +1 frameshifting and a reduction in codon-dependent translation
speed.[26,27] In yeast, deletion mutants of individual
“Elp” genes show growth defects in the presence of stressors
such as high salt, caffeine, and 6-azouracil.[8,9,11,28] Phenotypes
of Elongator deficient mutants in higher eukaryotes are more severe
but are tissue-dependent. In mice, aberrations in Elongator function
within germ cells, neuronal cells, and retinal cells were shown to
cause infertility, neurodegeneration, and blindness, respectively.[29−32] In humans, an exon-skipping mutation of the gene encoding hELP1
causes Familial Dysautonomia, a congenital neurodevelopmental disease
featuring an unusually low number of neurons in the sensory and autonomic
nervous systems, which result in symptoms such as pain insensitivity,
gastrointestinal dysfunction, and scoliosis.[33−35] Gene mutations
in other human Elongator subunits have also been associated with Amyotrophic
lateral sclerosis, Rolandic epilepsy, and intellectual disability.[36−45] More recently, germline loss-of-function mutation of the hELP1 gene
was found to be linked to the malignant brain cancer medulloblastoma.[39]Despite growing evidence supporting the
direct relevance of Elongator
in different human pathologies, the effects of disease-associated
mutations on human Elongator are not fully understood. This is due
in part to the fact that much of the current biochemical and structural
knowledge on Elongator and its components is derived from yeast Elongator
and bacterial orthologues of Elp3. Here, we reconstituted and characterized
the biochemical and structural properties of human Elongator subunits/subassemblies
and core human Elongator (hELP1/2/3). Negative stain EM analysis of
human core Elongator and hELP4/5/6 revealed a similar overall architecture
and subunit arrangement to yeast core Elongator and yElp4/5/6. These
structural data, together with results from pulldown assays, indicated
that hELP1 stabilizes hELP3 while hELP2 rigidifies the hELP1/3 subassembly.
Complementary tRNA binding assays showed that substrate interaction
is enhanced upon core Elongator assembly. Collectively, our work sheds
light on the assembly pathway of human Elongator and potential role
of hELP2 in supporting Elongator function.
Results
Conserved Architecture
of Human Core Elongator
To gain
insights into the structural properties of human Elongator, we attempted
to reconstitute the full 6-subunit human Elongator using the baculovirus-insect
cell-based system. We selected the biGBac series of plasmids, which
offers a simple procedure for generating a co-expression construct
containing multiple genes.[40] In short,
we first cloned the six genes encoding full-length hELP1 to hELP6
into pLIB entry vectors (with a 3xFLAG tag engineered to the C-terminus
of hELP1 and a His tag engineered to the N-terminus of hELP2) and
then used Gibson assembly to link all six Elongator genes into a multigene
cassette within a pBIG2 vector. Baculovirus generated from bacmid
derived from this co-expression construct was used to infect Sf9 cells for recombinant protein expression. We conducted
anti-FLAG affinity chromatography on lysates prepared from these infected
cells. We found that the eluted fractions showed high levels of hELP1,
hELP2, and hELP3 but a complete absence of hELP4, hELP5, and hELP6.
In agreement with this observation, we were unable to overexpress
nor purify the hELP4/5/6 subcomplex from Sf9 cells
using a separate co-expression construct that contains only these
three genes (data not shown). Nevertheless, these observations demonstrated
that similar to yeast Elongator, human core Elongator (hELP1/2/3)
can form a stable assembly in the absence of hELP4/5/6.To characterize
the structural properties of human core Elongator, we first applied
size-exclusion chromatography or gradient fixation (GraFix) to improve
sample purity by removing excess FLAG-tagged hELP1 captured in the
initial anti-FLAG affinity step. The extra polishing step enabled
us to obtain human core Elongator with the three subunits present
at near stoichiometric level (Figure A). We next subjected GraFix purified human core Elongator
to negative stain EM analysis. Raw images showed the presence of bi-lobal
particles reminiscent to yeast core Elongator (Figure B) as well smaller particles, which may represent
alternate views, dissociated subunits, or “monomeric”
hELP1/2/3. Reference-free 2D classification showed that 51% of the
particles make up the dominant “moth”-shaped class averages
that resembled the 2D averages obtained from previous studies of yeast
core Elongator (Figures B, S2A), while 34% of the particles produced
averages reminiscent of a single lobe of yElp1/2/3. These results
suggest that yeast and human core Elongator share a conserved overall
architecture. Similarly, we observed high variability in the distance
between the two hELP1/2/3 lobes, as was observed for yElp1/2/3.[22] However, unlike our previously determined 2D
averages of yeast core Elongator, the experimental 2D averages of
human core Elongator lacks sufficient details to discern intersubunit
and domain boundaries, indicating that there is a higher degree of
intrasubunit conformational flexibility compared to yeast core Elongator.[22] This flexibility precluded determination of
a 3D reconstruction of the hELP1/2/3 complex as well as high-resolution
analysis of this complex by cryo-EM.
Figure 1
Purification and architecture of human
core Elongator and its subassemblies.
(A) SDS-PAGE of human core Elongator subunits purified by size-exclusion
chromatography. Gel was stained with Coomassie brilliant blue. Migration
of molecular weight markers is indicated on the left and expected
migration of each subunit is indicated on the right. (B) Top: Representative
segment of an electron micrograph of negatively stained hELP1/2/3
purified by GraFix. Red squares correspond to intact core Elongator.
Bottom: Representative 2D class averages of hELP1/2/3 particles. Averages
that clearly resemble a bi-lobal dimeric shape are on the left, and
averages that are single lobes are shown as monomeric on the right.
Uncropped images of all 2D averages are shown in Figure S2A. (C) Representative segment of an electron micrograph
of negatively stained hELP1 purified by GraFix. Bottom: Representative
2D class averages from reference-free classification of hELP1 particles
generating monomeric and dimeric averages. Uncropped images of all
2D averages are shown in Figure S3A. (D)
Top: Representative segment of an electron micrograph of negatively
stained hELP1/3 purified by GraFix. Bottom: Representative 2D class
averages of best-resolved hELP1/3 particles. Uncropped images of all
2D averages are shown in Figure S3B.
Purification and architecture of human
core Elongator and its subassemblies.
(A) SDS-PAGE of human core Elongator subunits purified by size-exclusion
chromatography. Gel was stained with Coomassie brilliant blue. Migration
of molecular weight markers is indicated on the left and expected
migration of each subunit is indicated on the right. (B) Top: Representative
segment of an electron micrograph of negatively stained hELP1/2/3
purified by GraFix. Red squares correspond to intact core Elongator.
Bottom: Representative 2D class averages of hELP1/2/3 particles. Averages
that clearly resemble a bi-lobal dimeric shape are on the left, and
averages that are single lobes are shown as monomeric on the right.
Uncropped images of all 2D averages are shown in Figure S2A. (C) Representative segment of an electron micrograph
of negatively stained hELP1 purified by GraFix. Bottom: Representative
2D class averages from reference-free classification of hELP1 particles
generating monomeric and dimeric averages. Uncropped images of all
2D averages are shown in Figure S3A. (D)
Top: Representative segment of an electron micrograph of negatively
stained hELP1/3 purified by GraFix. Bottom: Representative 2D class
averages of best-resolved hELP1/3 particles. Uncropped images of all
2D averages are shown in Figure S3B.
hELP2 Locks hELP1/3 into a More Rigid Dimeric
Assembly
To examine the subunit organization of human core
Elongator, we next
used the baculovirus-insect cell system to produce individual Elongator
subunits and subassemblies. We first focused on the largest subunit,
hELP1, which forms the main scaffold that mediates dimerization and
substrate binding. We were able to produce full-length ELP1 alone
as well as hELP1 in complex with hELP3 (hELP1/3) (Figure A). We next characterized these
samples by negative stain EM. Raw images showed that hELP1 is structurally
heterogeneous (Figure C). 2D class averages obtained from reference-free classification
show overall morphologies that appear to correspond to the monomeric
and dimeric states of the protein (Figure C). Although only ∼10% of the class
averages represent dimeric hELP1 compared to 87% for monomeric hELP1,
we believe the actual dimer-to-monomer ratio is higher in solution.
Notably, the asymmetry of the hELP1 dimer can lead to one half of
the dimer being averaged out in the 2D image analysis procedure. Indeed,
our size-exclusion chromatography coupled to multiangle light scattering
(SEC-MALS) analysis suggested that hELP1 is predominantly dimeric
(Figure S4). Systematic comparison of experimental
2D class averages corresponding to monomeric hELP1 with the 3D model
of monomeric hELP1 (generated from the core yeast Elongator cryo-EM
structure) showed remarkable conservation in the overall morphology
(Figure A). The region
corresponding to the hELP1 C-terminal dimerization domain (hereafter
“CTD”) was blurry in all class averages, indicating
that the CTD is more conformationally flexible compared to the N-terminal
WD40 domains of this protein.
Figure 2
Structural comparison of hELP1 and ELP1/3 with
their yeast orthologues.
(A) Left: Representative 2D class averages of hELP1 particles with
labels denoting the approximate location of hELP1 domains. Centre:
3D model of monomeric yElp1 (PDB: 6QK7) in orientations corresponding
to the 2D averages to the left. Right: 2D projections generated from
the 3D models in the center. (B) Left: Representative 2D class averages
of hELP1/3 particles with labels denoting the approximate location
of hELP1 domains and hELP3. Centre: 3D model of monomeric yElp1/3
(PDB: 6QK7) in orientations corresponding to the 2D averages to the
left. Right: 2D projections generated from the 3D models in the center.
A color legend corresponding to the 3D models is shown at the bottom.
Structural comparison of hELP1 and ELP1/3 with
their yeast orthologues.
(A) Left: Representative 2D class averages of hELP1 particles with
labels denoting the approximate location of hELP1 domains. Centre:
3D model of monomeric yElp1 (PDB: 6QK7) in orientations corresponding
to the 2D averages to the left. Right: 2D projections generated from
the 3D models in the center. (B) Left: Representative 2D class averages
of hELP1/3 particles with labels denoting the approximate location
of hELP1 domains and hELP3. Centre: 3D model of monomeric yElp1/3
(PDB: 6QK7) in orientations corresponding to the 2D averages to the
left. Right: 2D projections generated from the 3D models in the center.
A color legend corresponding to the 3D models is shown at the bottom.For hELP1/3, while we clearly observed particles
resembling dimeric
hELP1/3 in raw EM images (Figure D), the majority of class averages obtained from 2D
analysis have overall morphology resembling single-lobe “monomeric”
yELP1/3 (2% dimeric, 96% monomeric) (Figure D). Like hELP1 alone, the CTD of hELP1 was
blurry in the hELP1/3 2D class averages, indicating that hELP3 does
not have stabilizing effects on the hELP1 CTD. Comparison of hELP1/3
class averages to the 3D model of yElp1/3 suggests that the orientation
of hELP3 relative to both WD40 domains of hELP1 is conserved from
yeast to humans (Figure B). Much like hELP1, the limited number of 2D averages corresponding
to dimeric hELP1/3 could be attributed to conformational flexibility
that prevents this complex from adopting a symmetrical dimer, leading
to one half of the hELP1/3 dimer being averaged out in the 2D image
analysis procedure. The fact that a significantly higher proportion
of 2D class average resembles the dimeric state in our earlier 2D
negative stain EM analysis of hELP1/2/3 indicated that hELP2 binding
likely reduces overall flexibility of hELP1/3 by locking the two lobes
in a more rigid symmetrical conformation.
hELP3 Stability Is Enhanced
by Complex Formation with hELP1
Despite trying different
methods to optimize expression, we were
unable to purify human ELP3 alone using our system. This was not unexpected
as previous studies on archaeal and bacterial Elp3 necessitate the
use of anaerobic conditions to preserve the integrity of the Fe–S
cluster present in this protein. Interestingly and as detailed earlier,
we were able to reconstitute an hELP1/3 subcomplex, indicating that
hELP1 stabilizes hELP3 and potentially prevents hELP3 from aggregating
and/or sequesters it from harmful effects in an aerobic environment.
Based on this observation, we hypothesized that the assembly of human
core Elongator likely begins with the formation of the hELP1-hELP3
subcomplex followed by the recruitment and binding of hELP2. To test
this hypothesis, we carried out in vitro co-immunoprecipitation assays
using the purified human core Elongator subunits and subassemblies.
We found that a very low amount of hELP2 was pulled down by immobilized
hELP1, indicating that hELP1 alone interacts weakly with hELP2 (Figure A). By contrast,
the hELP1/3 subassembly showed stronger interaction with hELP2, as
shown by an increase in the signal for hELP2 in the pulldown (Figure B). Interestingly,
the assembly of hELP2 into core Elongator appears to be limited by
the amount of hELP3, as demonstrated by the amount of hELP2 corresponding
to the lesser amount of hELP3 present, despite an excess of hELP1.
In summary, our pulldown results support an assembly pathway whereby
hELP1 and hELP3 form a structural platform for hELP2 to bind and further
stabilize the complex.
Figure 3
Intersubunit assembly of human core Elongator proteins.
(A) In
vitro pulldown assay using FLAG-tagged hELP1 immobilized on M2-FLAG
resin as prey and his-tagged hELP2 as bait. Input and pulldown fractions
were analyzed by SDS-PAGE followed by an anti-FLAG (top) or anti-His
(middle) Western blot or by Coomassie blue staining (bottom). (B)
In vitro pulldown assay using FLAG-tagged hELP1/3 immobilized on M2-FLAG
resin as prey and his-tagged hELP2 as bait. Input and pulldown fractions
were analyzed by SDS-PAGE followed by an anti-FLAG (top) or anti-His
(middle) Western blot or by Coomassie staining (bottom). (C) Negative
control pulldown assay using unloaded M2-FLAG resin as bait and purified
His-hELP2 as bait. Input and pulldown fractions were analyzed by SDS-PAGE
followed by an anti-FLAG (top) or anti-His (middle) Western blot or
by Coomassie blue staining (bottom).
Intersubunit assembly of human core Elongator proteins.
(A) In
vitro pulldown assay using FLAG-tagged hELP1 immobilized on M2-FLAG
resin as prey and his-tagged hELP2 as bait. Input and pulldown fractions
were analyzed by SDS-PAGE followed by an anti-FLAG (top) or anti-His
(middle) Western blot or by Coomassie blue staining (bottom). (B)
In vitro pulldown assay using FLAG-tagged hELP1/3 immobilized on M2-FLAG
resin as prey and his-tagged hELP2 as bait. Input and pulldown fractions
were analyzed by SDS-PAGE followed by an anti-FLAG (top) or anti-His
(middle) Western blot or by Coomassie staining (bottom). (C) Negative
control pulldown assay using unloaded M2-FLAG resin as bait and purified
His-hELP2 as bait. Input and pulldown fractions were analyzed by SDS-PAGE
followed by an anti-FLAG (top) or anti-His (middle) Western blot or
by Coomassie blue staining (bottom).
Integration of hELP2 Enhances Human Core Elongator Interaction
with tRNA
We next evaluated the contribution of different
core Elongator subunits toward substrate recognition and binding.
To this end, we generated a putative substrate tRNA of Elongator,
tRNAGluUUC, by in vitro transcription
and used this reagent for electrophoretic mobility shift assays (EMSAs)
to assess binding. We observed minimal binding of hELP1 alone to tRNA,
requiring a 10- to 50-fold molar excess of the protein to cause a
shift in migration of the tRNA within the gel (Figures A, S1A). Similarly,
the observed affinity of hELP2 for tRNAs within our study was quite
weak, requiring a larger molar excess of hELP2 for the formation of
a ternary hELP2-tRNA complex (Figures B, S1B). Significant binding
of Elongator proteins to tRNAGluUUC was observed
when we carried out the EMSA using the hELP1/3 subassembly, where
we could detect binding even at submolar ratios of hELP1/3:tRNA (Figures C, S1C). Despite very minimal direct binding between hELP2 and
tRNAGluUUC, we observed an increase in substrate
binding when using the fully assembled core Elongator (hELP1/2/3)
compared to hELP1/3 (Figures D, S1D), further demonstrating
a role for hELP2 in stabilizing this assembly. This mode of substrate
interaction is consistent with the recent cryo-EM structure of yeast
core Elongator in complex with tRNAAlaUGC, where
direct interactions between the substrate and both hELP1 and hELP3
were observed.[24]
Figure 4
Hierarchical interactions
of human core Elongator subassemblies
with tRNA. EMSA demonstrating the interaction between recombinant
tRNAGluUUC and Elongator subassemblies. 100
nM tRNA was incubated with the indicated amount of hELP1 (A), hELP2
(B), hELP1/3(C), or hELP1/2/3 (D) and run on a 5% native polyacrylamide
gel. Nucleic acids within the gel were then stained and visualized
using SYBR Gold and visualized. Migration of the various species of
tRNA and tRNA:protein complexes are indicated to the right of each
gel.
Hierarchical interactions
of human core Elongator subassemblies
with tRNA. EMSA demonstrating the interaction between recombinant
tRNAGluUUC and Elongator subassemblies. 100
nM tRNA was incubated with the indicated amount of hELP1 (A), hELP2
(B), hELP1/3(C), or hELP1/2/3 (D) and run on a 5% native polyacrylamide
gel. Nucleic acids within the gel were then stained and visualized
using SYBR Gold and visualized. Migration of the various species of
tRNA and tRNA:protein complexes are indicated to the right of each
gel.
Human ELP4/5/6 Subcomplex
Forms a Hexameric ATPase Ring
As we were unable to express
hELP4/5/6 using the baculovirus-insect
cell system, we tested the ability of a bacterial expression system
to produce recombinant hELP4/5/6. We first cloned the genes encoding
each of the three subunits to a pQLink vector and then assembled a
multigene, multipromoter co-expression plasmid by ligase independent
cloning.[41] Despite low levels of expression,
we were able to recover a small amount of hELP4/5/6 using a combination
of nickel-based affinity chromatography, ion exchange chromatography,
and gel filtration (typical yield of ∼1 μg/L of E. coli expression culture). We subjected purified
hELP4/5/6 to negative stain EM analysis. Raw micrographs revealed
ring-shaped particles resembling the morphology of yElp4/5/6 (Figure A). 2D classification
and subsequent 3D reconstruction generated a density map in which
we were able to fit the crystal structure of the truncated yElp4/5/6
subcomplex (Figure B). However, the limited resolution of our EM density map precluded
precise subunit assignment to each of the lobes. Interestingly, we
observed unaccounted density after this fitting. This density might
correspond to the missing structural elements resulting from truncation
of the yElp4 subunit in the previous crystallized assembly.
Figure 5
Molecular architecture
and assembly of the hELP4/5/6 subcomplex.
(A) (Top) Representative segment of a negative stained micrograph
generated using purified hELP4/5/6. (Bottom) Representative 2D class
averages of hELP4/5/6 generated using Relion v3.0. Uncropped image
of all 100 class averages are shown in Figure S2B. (B) 3D reconstruction of hELP4/5/6 generated using ab
initio reconstruction in cryoSPARC v2.14. Crystal structure of the
truncated yElp4/5/6 subcomplex (PDB ID: 4A8J) was docked into the
3D model and individual subunits are denoted based on color. (C) In
vitro pulldown assay using FLAG-tagged hELP1, hELP1/3, or hELP1/2/3
immobilized on M2-FLAG resin as prey and Strep-tagged hELP4/5/6 as
bait. Flow through fractions (FT) were collected to detect unbound
protein and any bound proteins (B) were eluted from the resin using
3xFLAG peptide. Input and pulldown fractions were analyzed by SDS-PAGE
followed by an anti-Strep Western blot.
Molecular architecture
and assembly of the hELP4/5/6 subcomplex.
(A) (Top) Representative segment of a negative stained micrograph
generated using purified hELP4/5/6. (Bottom) Representative 2D class
averages of hELP4/5/6 generated using Relion v3.0. Uncropped image
of all 100 class averages are shown in Figure S2B. (B) 3D reconstruction of hELP4/5/6 generated using ab
initio reconstruction in cryoSPARC v2.14. Crystal structure of the
truncated yElp4/5/6 subcomplex (PDB ID: 4A8J) was docked into the
3D model and individual subunits are denoted based on color. (C) In
vitro pulldown assay using FLAG-tagged hELP1, hELP1/3, or hELP1/2/3
immobilized on M2-FLAG resin as prey and Strep-tagged hELP4/5/6 as
bait. Flow through fractions (FT) were collected to detect unbound
protein and any bound proteins (B) were eluted from the resin using
3xFLAG peptide. Input and pulldown fractions were analyzed by SDS-PAGE
followed by an anti-Strep Western blot.We next investigated how hELP4/5/6 interacts with human core Elongator.
We carried out in vitro pulldown assays using hELP4/5/6
as prey against FLAG-tagged hELP1, hELP1/3, or hELP1/2/3 purified
from insect cells and immobilized on anti-FLAG resin. Contrary to
previous reports, we were unable to detect interaction between hELP1
alone and hELP4/5/6 (Figure C), suggesting the previously observed co-immunoprecipitation
of hELP1 with hELP6 was likely through a bridging protein.[18] We found that both hELP1/3 and hELP1/2/3 complexes
were able to pulldown hELP6 (Figure C), indicating that hELP3 is the primary interface
for the hELP4/5/6 subcomplex binding to core Elongator. Because of
very limited yield of purified hELP4/5/6, we were unable to carry
out experiments to test the effects of this complex on human core
Elongator-tRNA substrate interaction. Based on the sequence and structural
similarities between the yeast and human homologs, we expect the observed
high affinity of yElp4/5/6 to tRNAGluUUC (Figure S1E,F) to be conserved in humans as well.
Discussion
Over the past decade, structural analyses of
yeast Elongator and
Elongator subunits/subassemblies from yeast and other bacterial species
have advanced our understanding of the overall architecture, subunit
organization, and substrate interaction of this tRNA modifying complex.[17−19,21−24] However, the extent to which
this knowledge can be applied to human Elongator remains unclear as
molecular studies on this orthologous complex, apart from human ELP1,
have lagged behind due in part to challenges in obtaining pure human
Elongator. Results from our negative stain EM analyses of human ELP1/2/3
and human ELP4/5/6 not only enable visualization of these two major
subassemblies of human Elongator for the first time but also demonstrated
that their overall architecture is conserved compared to those of
the well-characterized yeast Elongator. However, we were unable to
capture images of full human Elongator as challenges in expressing
hELP4/5/6 in insect, bacterial, and human cells (data not shown) have
precluded us from reconstituting the full 6-subunit assembly. Examination
of different available databases showed that the levels of mRNA of
hELP4, hELP5, and hELP6 are lower than that of hELP1, hELP2, and hELP3
across different human tissues and cell types, a scenario that mirrored
what was observed in yeast cells.[22,46] We postulate
that much like in yeast, the low level of hELP4/5/6 in the cytoplasm
of human cells would restrict loading of this subassembly onto hELP1/2/3,
resulting in an overall asymmetric architecture of human full Elongator.
An early experimental evidence supporting this hypothesis is that
the original multistep purification showed stoichiometric level of
six subunits in the purified human Elongator which can only be achieved
if only one hELP4/5/6 ring is loaded onto hELP1/2/3.[47]It is generally accepted that full Elongator involves
the assembly
of two discrete subcomplexes (hELP4/5/6 and hELP1/2/3) that were formed
independently. Yet, little is known how the different subunits come
together to form each subcomplex because of previous studies focusing
primarily on characterizing preassembled core Elongator or full Elongator
from yeast cells. The ability to produce individual human Elongator
subunits and distinct subassemblies offered us the opportunity to
investigate this poorly understood aspect of Elongator biology. Through
examining the biochemical and structural features of these subunits
and subassemblies, we were able to gain insights into the mechanism
of Elongator assembly. By validating that full-length hELP1 can form
a dimer in the absence of other Elongator subunits (Figure S4), we confirmed that this largest subunit forms the
scaffold for complex assembly. Our subsequent and serendipitous discovery
that hELP3 can only be purified when co-expressed with hELP1 indicated
that the hELP1 scaffold stabilizes hELP3 and that our reconstituted
hELP1/3 represents an assembly intermediate. The observation that
hELP2 binds more strongly to hELP1/3 compared to hELP1 indicated that
the binding of two copies of hELP2 to the periphery of hELP1/3 likely
represents the final step in the assembly of core Elongator. Furthermore,
the integration of this last subunit also rigidifies the core assembly,
likely priming it for tRNA substrate binding and the recruitment of
hELP4/5/6. Deletion mutants of yElp4, yElp5, and yElp6 share the same
phenotypes as mutants carrying deletions of core Elongator genes (yElp1,
yElp2, and yElp3). This suggested that, despite apparently being less
stable, hELP4/5/6 is an indispensable component of Elongator. How
hELP4/5/6 precisely modulates the activity and/or alters the conformation
of core Elongator would require acquisition of high-resolution structural
data on apo-full Elongator and full Elongator in complex with the
tRNA substrate.
Materials and Methods
Plasmids and Cloning
The cDNAs encoding hELP1 (isoform
1) with a C-terminal 3xFLAG tag and hELP2 (isoform 2) were codon optimized
for expression in S. frugiperda (Sf9) cells and synthesized as 5 (hELP1) or 2 (hELP2) GeneArt
fragments (Thermo Fisher). The fragments were then assembled into
a pLIB (hELP1) or pLIB-10xHis (hELP2) vector via Gibson assembly.
cDNAs encoding hELP3, hELP4, hELP5, and hELP6 were purchased from
the DNASU repository then subcloned into pLIB (hELP3, hELP4, hELP5,
and hELP6), pQLinkH (hELP4), pQLinkN (hELP5) or pQLink-TwinStrepII
(hELP6) vectors. hELP1-3xFLAG, 10xHis-hELP2, and hELP3 CDS were combined
into one pBIG1a, and hELP4, hELP5, and hELP6 CDS were combined into
one pBIG1b vector by Gibson assembly following the published protocol,[40] and 6xHis-hELP4, hELP5, and TwinStrepII-hELP6
CDS were combined into one pQLink vector by ligation-independent cloning,
following the published protocol.[41] A table
summarizing all plasmids used in this study is provided as Table S1.
Baculovirus Generation
and Protein Expression
The insect
cell expression plasmid was transformed into DH10EMBacY cells for
bacmid production. Bacmids were isolated using an isopropanol precipitation
protocol and the presence of all cDNAs was confirmed via PCR. Then,
2.5 μg of bacmid was combined with 5 μL of TransIT transfecting
reagent (Mirus) in 200 μL of Grace’s media. The combined
mixture was used to infect Sf9 cells freshly seeded in 6-well plates
at a density of 0.8 × 106 cells/mL and the infection
was allowed to proceed for 72 h. The supernatant containing the baculovirus
(P1) was harvested, and the virus was propagated for another generation
in 6-well plates (P2). P3 virus was produced by infecting a 50 mL
suspension culture grown in ESF921 media (Expression Systems) with
500 μL of P2 virus for 72 h and harvesting the virus-containing
supernatant. For large-scale protein expression, 250 or 500 mL cultures
of Sf9 cells were infected at a density between 2
and 3 × 106 cells/mL with P3 virus at a ratio of 1
mL/100 × 106 cells. Cell pellets were harvested by
centrifugation after 66–72 h of expression, washed with PBS,
then flash-frozen in liquid nitrogen.The pQLink-hELP4/5/6 plasmid
was transformed into T7 Express E. colicells via heat shock. A single colony was used to inoculate a 5 mL
overnight culture and grown for 16–18 h. One liter of expression
cultures were inoculated with 1 mL of the overnight culture and grown
at 37 °C until reaching an OD600 of 0.6. The expression
was induced by adding IPTG to a final concentration of 1 mM and allowed
to continue for 18 h at 16 °C. Following protein expression,
cells were harvested by centrifugation at 4,000 rpm in a JLA-9.1 rotor
(Beckman), pellets were washed with PBS, then flash-frozen in liquid
nitrogen.
Protein Purification
Cell pellets of hELP1, hELP2,
hELP1/3, hELP1/2/3, or hELP4/5/6 were all resuspended in lysis buffer
(40 mM HEPES-NaOH pH 7.4, 300 mM NaCl, 10% (v/v) glycerol, and 0.01%
DDM) containing protease inhibitors (1 mM PMSF, 1× Protease Inhibitor
cocktail EDTA-free (Roche), 25 μg/mL benzamidine, and 0.25 U/mL
benzonase). Cells were lysed by sonication on ice using a Branson
Sonifier 450 set to 50% duty cycle and output control 5 for 60 s followed
by 120 s of cooling, repeated six times. The lysate was cleared by
centrifugation for 30 min at 18,000 rpm (JA-25.50 rotor, Beckman).
The supernatant was then incubated with M2-FLAG resin (hELP1, hELP1/3,
hELP1/2/3) (Sigma) or Ni-NTA beads (hELP2, hELP4/5/6) (Thermo Fisher)
for 1 h at 4 °C while rocking. The mixtures were then passed
over 5 mL Pierce centrifuge columns (Thermo Fisher) and the flow through
discarded. The settled resin was washed with six washes of 10CV lysis
buffer alone (M2-FLAG) or lysis buffer supplemented with 50 mM imidazole
(NiNTA). Proteins were eluted from the columns by incubation with
4 × 1 CV lysis buffer supplemented with 0.5 mg/mL 3xFLAG peptide
(M2-FLAG) or with 250 mM imidazole (NiNTA). Elution fractions were
then concentrated to 500 μL using a 100 k MWCO concentrator
(Millipore). For use in pulldown assays or EMSAs, the proteins were
loaded onto a Superdex200 (hELP1, hELP2, hELP4/5/6) or a Superose
6 (hELP1/3, hELP1/2/3) gel filtration column (Cytiva) equilibrated
with SEC buffer (40 mM HEPES-NaOH pH 7.4, 150 mM NaCl, 5% glycerol,
0.01% DDM). For use in EM studies, the proteins were loaded on a 15–30%
glycerol gradient with 0–0.1% glutaraldehyde, and centrifuged
for 16 h at 40,000 rpm (SW-55 rotor, Beckman). Elution peak fractions
were analyzed by SDS-PAGE for purity. Protein concentrations were
measured by a Bradford assay in 250 μL reactions, following
the manufacturer’s instructions (BioRad). hELP1 and hELP2 proteins
were flash-frozen in liquid nitrogen and stored at −70 °C
until use in pulldowns or EMSAs. hELP1/3, hELP1/2/3, and hELP4/5/6
samples were used fresh for all experiments.
Negative Stain EM and Imaging
Processing
Purified hELP1,
hELP1/3, hELP1/2/3, and hELP4/5/6 were adsorbed to glow discharged
carbon-coated grids and stained with uranyl formate. Stained hELP1,
hELP1/3, or hELP1/2/3 specimens were examined using a Talos L120C
transmission electron microscope (Thermo Fisher Scientific) operated
at an acceleration voltage of 120 kV and equipped with a Ceta camera.
hELP4/5/6 samples were imaged using a Tecnai Spirit transmission electron
microscope (FEI Company) operated at an acceleration voltage of 120
kV and equipped with an Eagle 4 K CCD camera.For hELP1, 220
micrographs were acquired at a nominal magnification of 45,000×
at a defocus of ∼1.2 μm at a pixel size of 2.228 Å/pixel.
Contrast transfer function (CTF) estimation for each micrograph was
carried out using CTFFIND4.[42] Two hundred
particles were manually picked then aligned to generate 2D class averages
for template-based autopicking in Relion 3.0. A total of 81,007 particles
were autopicked and extracted with a box size of 200 pixels. Particles
were then exported to cryoSPARC v3.2[43] and
subjected to 2D classification. A total of 61,968 distinct particles
were subjected to another round of 2D classification into 50 classes
(Figure S3A), from which particle distribution
was calculated and the figures were generated.For hELP1/3,
150 micrographs were acquired at a nominal magnification
of 45,000× at a defocus of ∼1.2 μm at a pixel size
of 2.228 Å/pixel. CTF estimation for each micrograph was carried
out using CTFFIND4. A total of 200 particles were manually picked
then aligned to generate 2D class averages for template-based autopicking
in Relion 3.0.[44] A total of 109,093 particles
were autopicked and extracted with a box size of 200 pixels. Particles
were then exported to cryoSPARC v3.2 and subjected to 2D classification
into 50 classes. A total of 75,859 particles classified into discrete
classes were subjected to a second round of 2D classification (Figure S3B), and representative class averages
were selected for figure generation.For hELP1/2/3, 100 micrographs
were acquired at a nominal magnification
of 45,000× at a defocus of ∼1.2 μm and binned twice
to obtain a pixel size of 4.53 Å/pixel. CTF estimation for each
micrograph was carried out using CTFFind4. Two hundred particles were
manually picked and then aligned to generate 2D class averages for
template-based autopicking in Relion 3.0. A total of 71,732 particles
were autopicked and extracted with a box size of 100 pixels. Particles
were then exported to cryoSPARC v3.2 and subjected to 2D classification,
where 38,529 particles were found to classify well and were subjected
to a second round of 2D classification (Figure S2A). The distribution of “dimeric” and “monomeric”
particles was calculated from these averages.For hELP4/5/6,
85 micrographs were acquired at a nominal magnification
of 49,000× at a defocus of ∼1 μm and binned twice
to obtain a pixel size of 4.67 Å/pixel. CTF estimation for each
micrograph was carried out using CTFFind4. A total of 286 particles
were manually picked and then aligned to generate 2D class averages
for template-based autopicking in Relion 3.0. A total of 35,272 particles
were autopicked and extracted with a box size of 60 pixels. Particles
were then subjected to 2D classification into 100 classes (Figure S2B). For 3D reconstruction, the micrographs
were processed in cryoSPARC v2.14, where CTF estimation was carried
out using CTFFind4; 50 particles were manually picked and averaged
into 2D classes for use as templates for autopicking, which yielded
64,734 particles. The particles were iteratively classified by 2D
averaging twice, and the remaining particles were used for ab initio
reconstruction of two 3D models; the more complete model was used
for subsequent docking using the crystal structure of yElp4/5/6 (PDB
ID: 4A8J).
tRNA Substrate Preparation
cDNA
encoding human tRNAGluUUC was synthesized and
placed downstream of
a T7 promoter in a pMA-T cloning vector (Thermo Fisher). The plasmid
was linearized in a 50 μL reaction by incubation with 2 μL
of SwaI for 1 h at 25 °C, then purified by phenol–chloroform
extraction. The linearized plasmid was then used as a template for
transcription using T7 RNA polymerase, following the manufacturer’s
protocol (NEB Quick High Yield RNA Synthesis Kit). The completed reaction
was incubated with 2 μL DNAseI for 15 min at 37 °C to digest
the template DNA, and the remaining tRNA was purified by phenol–chloroform
extraction followed by ethanol precipitation. Next, tRNA refolding
was carried out by incubating the purified tRNA at 85 °C for
1 min then cooled to 25 °C over 60 min. Correctly folded tRNAs
were separated from unfolded or misfolded species by size-exclusion
chromatography using a Superdex 75 column (Cytiva). Samples from every
step of the procedure were analyzed by agarose gel electrophoresis
to ensure purity and correct size.
Electrophoretic Mobility
Shift Assay
All EMSAs were
carried out using 5% native polyacrylamide gels made from 40% acrylamide/bis-acrylamide,
37.5:1 (BioRad), which were prerun in 0.5× TBE alone for 1 h
at 150 V, at 4 °C. Then, 100 nM tRNAGluUUC was incubated with 0–5 μM hELP1, hELP1/3, hELP1/2/3,
or yyElp4/5/6 and diluted to 9 μL reactions in EMSA buffer (40
mM HEPES pH 7.4, 100 mM NaCl, 1 mM MgCl2). Reactions were
incubated on ice for 1 h, and then 1 μL of 50% glycerol was
added for a final concentration of 5% (v/v). Samples were then loaded
on native PAGE gels and subjected to electrophoresis for 1 h at 150
V at 4 °C. tRNA and tRNA–protein complexes were stained
on the gels by incubating with 50 mL of 1× SYBR Gold for 30 min
under rotation. The gels were subsequently imaged using a ChemiDoc
MP imaging system (BioRad). The gels were then stained for proteins
using PAGE blue following the manufacturer’s instructions (Thermo
Scientific) and imaged using the ChemiDoc MP.
Pulldown Assays
First, 1 μM hELP1-3xFLAG or hELP1-3xFLAG/hELP3
was combined with 1 μM 10xHis-hELP2 in 200 μL reactions
and incubated with 50 mL of M2-FLAG resin for 1 h at 4 °C under
rotation. The M2-FLAG resin was isolated by centrifugation for 2 min
at 5000 × g, and the supernatant was collected
to analyze unbound protein. The resin was then washed three times
with 500 μL of pulldown buffer by resuspending the slurry in
buffer and collecting the resin by centrifugation. Bound proteins
were the eluted by incubation with 200 μL of 0.5 mg/mL 3xFLAG
peptide for 30 min at 4 °C (“Pulldown”). Then,
1 μM hELP1, hELP1/3, or hELP2 alone (“Input”),
along with FLAG elution fractions from each pulldown were loaded evenly
across 3 SDS-PAGE gels. Two gels were then transferred to nitrocellulose
membranes by wet transfer for 1.5 h at 100 V, and the third gel was
stained using Coomassie blue. Membranes were blocked for 1 h at RT
with a 5% skimmed milk solution then incubated with a 1:2000 dilution
of mouse anti-FLAG antibody (Sigma) or mouse anti-His antibody for
1 h at RT. Blots were then washed and incubated with a 1:10,000 dilution
of anti-mouse IRDye680 (Li-Cor BioSciences) secondary antibody. Blots
and stained gels were then imaged using a ChemiDoc MP.
Authors: Julie S Cohen; Siddharth Srivastava; Kelly D Farwell; Hsiao-Mei Lu; Wenqi Zeng; Hong Lu; Elizabeth C Chao; Ali Fatemi Journal: Am J Med Genet A Date: 2015-04-02 Impact factor: 2.802
Authors: S L Anderson; R Coli; I W Daly; E A Kichula; M J Rork; S A Volpi; J Ekstein; B Y Rubin Journal: Am J Hum Genet Date: 2001-01-22 Impact factor: 11.025
Authors: Claire L Simpson; Robin Lemmens; Katarzyna Miskiewicz; Wendy J Broom; Valerie K Hansen; Paul W J van Vught; John E Landers; Peter Sapp; Ludo Van Den Bosch; Joanne Knight; Benjamin M Neale; Martin R Turner; Jan H Veldink; Roel A Ophoff; Vineeta B Tripathi; Ana Beleza; Meera N Shah; Petroula Proitsi; Annelies Van Hoecke; Peter Carmeliet; H Robert Horvitz; P Nigel Leigh; Christopher E Shaw; Leonard H van den Berg; Pak C Sham; John F Powell; Patrik Verstreken; Robert H Brown; Wim Robberecht; Ammar Al-Chalabi Journal: Hum Mol Genet Date: 2008-11-07 Impact factor: 6.150